Showing 1,781 - 1,800 results of 10,572 for search '"tumors"', query time: 0.09s Refine Results
  1. 1781

    Pharmacokinetic and Biodistribution Assessment of a Near Infrared-Labeled PSMA-Specific Small Molecule in Tumor-Bearing Mice by Joy L. Kovar, Lael L. Cheung, Melanie A. Simpson, D. Michael Olive

    Published 2014-01-01
    “…In vivo targeting and clearance properties were determined in tumor-bearing mice. Organs and tumors were excised and imaged to assess probe localization. …”
    Get full text
    Article
  2. 1782

    MRI and FDG PET/CT Findings for Borderline Brenner Tumor of the Ovary: A Case Report and Literature Review by Hiroki Matsutani, Go Nakai, Takashi Yamada, Kazuhiro Yamamoto, Masahide Ohmichi, Keigo Osuga

    Published 2020-01-01
    “…The imaging features of borderline Brenner tumor (BT) of the ovary are very limited, especially regarding apparent diffusion coefficient (ADC) value and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET)/CT. …”
    Get full text
    Article
  3. 1783

    Calculation of Involved and Noninvolved Organs Doses in Carbon Therapy of Brain Tumor Using GEANT4 Simulation Toolkit by Maria Ahmadi, Seyed Mohammad Motevalli, Payvand Taherparvar, Vahid zanganeh

    Published 2024-10-01
    “…Weight factors were employed to generate a Spread Out Bragg Peak (SOBP).Material and Methods: The study used the ORNL-MIRD phantom to simulate carbon therapy for brain tumors, finding that the optimal energy range for carbon ions was 2420-2560 MeV to effectively cover the tumor. …”
    Get full text
    Article
  4. 1784
  5. 1785

    Ocular Inflammatory Myofibroblastic Tumor in the Left Eye with Phthisis Right Eye: A Rare Occurrence in a Child by Sangeeta Shah, Badri Prasad Badhu, Poonam Lavaju, Anju Pradhan

    Published 2015-01-01
    “…Inflammatory myofibroblastic tumor (IMT) is a benign pseudoneoplastic inflammatory condition with the potential for persistent local growth and recurrence that rarely affects the orbit. …”
    Get full text
    Article
  6. 1786
  7. 1787
  8. 1788

    PER3 suppresses tumor metastasis of oral squamous cell carcinoma by promoting HIF-1α degradation by Yaoxu Li, Bing Li, Kai Yang, Lihua Zhu, Hong Tang, Yinpei Huang, Jinhai Deng, Jun Duan

    Published 2025-02-01
    “…The low expression of period circadian regulator 3 (PER3) in head and neck squamous cell carcinoma is closely correlated with tumor size and invasion depth. Hypoxia-inducible factor 1 subunit alpha (HIF-1α) regulates epithelial-mesenchymal transition (EMT) transcription factors, activates EMT, and promotes tumor metastasis. …”
    Get full text
    Article
  9. 1789

    Late Recurrence in Ovarian Dysgerminoma Presenting as a Primary Retroperitoneal Tumor: A Case Report and Review of the Literature by Yuichiro Sato, Tohru Hayashi, Hidetaka Yamamoto, Ichiro Niina, Naoya Kuroki, Takeshi Iwamura, Junji Onishi

    Published 2020-01-01
    “…Ovarian dysgerminoma is a rare type of germ cell tumor. The majority of patient relapses occur within 2 years of diagnosis. …”
    Get full text
    Article
  10. 1790

    Establishment of a Model of Microencapsulated SGC7901 Human Gastric Carcinoma Cells Cocultured with Tumor-Associated Macrophages by Jin-Ming Zhu, Xiu-Lian Quan, Shi-Chao Han, Xue-Jun Fan, He-Ming Li, Shan-Shan Liang, Xi Chen, Ruo-Yu Wang, Xue-Ning Ji

    Published 2018-01-01
    “…For further elucidation of the mechanism, a culture system mimicking the microenvironment of the tumor in humans was needed. We established a model of microencapsulated SGC7901 human GC cells and evaluated the effects of coculturing spheres with tumor-associated macrophages (TAMs). …”
    Get full text
    Article
  11. 1791
  12. 1792
  13. 1793

    p53-loss induced prostatic epithelial cell plasticity and invasion is driven by a crosstalk with the tumor microenvironment by Darya Yanushko, Beatriz German Falcon, Rana El Bizri, Despoina Pervizou, Robin Dolgos, Céline Keime, Tao Ye, Christelle Thibault-Carpentier, Clementine Le Magnen, Sandrine Henri, Gilles Laverny, Daniel Metzger

    Published 2025-01-01
    “…Moreover, we show that the transcriptomic signature of this cell population is prominent in tumors of patients with high-risk prostate cancer or metastatic disease. …”
    Get full text
    Article
  14. 1794

    Preoperative MRI radiomic analysis for predicting local tumor progression in colorectal liver metastases before microwave ablation by Angelo Della Corte, Martina Mori, Francesca Calabrese, Diego Palumbo, Francesca Ratti, Gabriele Palazzo, Alessandro Pellegrini, Domenico Santangelo, Monica Ronzoni, Emiliano Spezi, Antonella Del Vecchio, Claudio Fiorino, Luca Aldrighetti, Francesco De Cobelli

    Published 2024-12-01
    “…Both combined models included MAMs and tumor regression grade; COMB-T1 also featured 10th percentile of signal intensity, while tumor flatness was present in COMB-T2.Conclusion MRI-based radiomic evaluation of CLMs is feasible and potentially useful for LTP prediction. …”
    Get full text
    Article
  15. 1795

    Diabetic Muscle Infarction of the Tibialis Anterior and Extensor Hallucis Longus Muscles Mimicking the Malignant Soft-Tissue Tumor by Yoshikuni Mimata, Kotaro Sato, Karen Tokunaga, Itsuko Tsukimura, Hiroshi Tada, Minoru Doita

    Published 2015-01-01
    “…MRI findings of DMI can be similar to that of a malignant soft-tissue tumor. So, it is necessary to consider the malignant soft-tissue tumor as one of the differential diagnoses of DMI.…”
    Get full text
    Article
  16. 1796
  17. 1797
  18. 1798
  19. 1799

    An in-depth examination of the fuzzy fractional cancer tumor model and its numerical solution by implicit finite difference method. by Hamzeh Zureigat, Saleh Alshammari, Mohammad Alshammari, Mohammed Al-Smadi, M Mossa Al-Sawallah

    Published 2024-01-01
    “…The cancer tumor model serves a s a crucial instrument for understanding the behavior of different cancer tumors. …”
    Get full text
    Article
  20. 1800

    The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage by Wilma E. Mesker, Jan M. C. Junggeburt, Karoly Szuhai, Pieter de Heer, Hans Morreau, Hans J. Tanke, Rob A. E. M. Tollenaar

    Published 2007-01-01
    “…Background: Tumor staging insufficiently discriminates between colon cancer patients with poor and better prognosis. …”
    Get full text
    Article